Geode Capital Management’s Annovis Bio ANVS Stock Holding History
Bought
Maintained
Sold
Other funds holding ANVS
SG
RS
Geode Capital Management's ANVS Position: Q3 2026 in Review
Geode Capital Management increased its Annovis Bio (ANVS) stake by 14% in Q3 2026, buying an estimated $66.2K and bringing the position to 324,422 shares worth $412K. The position accounts for ﹤0.01% of the portfolio, ranked #3635.
Geode Capital Management first reported a position in ANVS in Q1 2021 and has held it in 23 quarters since. The position peaked at $3.3M in Q2 2021. 27 funds tracked by Wall St. Rank hold ANVS as of Q3 2026.
- Geode Capital Management held 324,422 shares of Annovis Bio worth $412K as of Q3 2026.
- Geode Capital Management bought 40,605 Annovis Bio shares in Q3 2026, an estimated $66.2K.
- Annovis Bio made up ﹤0.01% of Geode Capital Management's portfolio in Q3 2026, its #3635 holding.
- Geode Capital Management first reported a position in Annovis Bio in Q1 2021 and has held it in 23 quarters since.
- Geode Capital Management's Annovis Bio position peaked at $3.3M in Q2 2021.
- 27 funds tracked by Wall St. Rank held Annovis Bio as of Q3 2026.
Based on Geode Capital Management's 13F filing for Q3 2026, filed 6 Nov 2026.